What Does Omega-7 Do for Your Body?

Omega-7 refers to a family of monounsaturated fatty acids, the most studied being palmitoleic acid, and research links it to effects on insulin sensitivity, blood lipids, skin hydration, and the health of mucous membranes throughout the body. Your body produces some omega-7 on its own, but you also get it from foods like macadamia nuts and sea buckthorn berries, and it has become a popular supplement in recent years. The science behind omega-7 is genuinely interesting, though messier than supplement marketing suggests, with some strong animal data, a handful of promising human trials, and a few results that complicate the simple “good fat” narrative.

Where Omega-7 Comes From

Palmitoleic acid, the main omega-7 fatty acid, is a 16-carbon chain with a single double bond. Unlike omega-3s, which are polyunsaturated fats with multiple double bonds, omega-7 is a monounsaturated fat. Your body can make it internally from palmitic acid, a common saturated fat, through the action of an enzyme called stearoyl-CoA desaturase-1 (SCD1).¹ This means omega-7 is not technically “essential” the way omega-3 and omega-6 are, since your cells can synthesize it. But the amount your body makes varies from person to person, and that variation turns out to be partly genetic. Studies of families with metabolic disorders have found that the activity of the desaturation pathway is about 48% heritable, with certain gene variants in a regulatory factor called HNF4-alpha influencing how efficiently your body converts palmitic acid into palmitoleic acid.²

Dietary sources of omega-7 include macadamia nuts (which contain roughly 17-20% palmitoleic acid by fat content), sea buckthorn berry oil, and smaller amounts in dairy fat and certain fish. Most omega-7 supplements on the market are derived from either sea buckthorn oil or purified palmitoleic acid extracted from fish oils. The source matters because sea buckthorn oil is a complex mixture of several fatty acids along with carotenoids and vitamin E, while purified palmitoleic acid supplements isolate just the one fatty acid. Some effects attributed to “omega-7” in studies may actually come from those companion compounds rather than palmitoleic acid alone.

Insulin Sensitivity and Blood Sugar

The most compelling basic-science finding about omega-7 is its role as a signaling molecule between fat tissue and the rest of the body. A landmark study in the journal Cell identified palmitoleic acid as a “lipokine,” a lipid hormone released by fat tissue that communicates with distant organs. In that research, palmitoleic acid strongly stimulated insulin signaling in muscle cells, boosted glucose uptake to a level comparable to insulin itself, and suppressed fat accumulation in the liver.³ When researchers infused palmitoleic acid into live mice, the animals needed significantly more glucose to maintain normal blood sugar levels during an insulin clamp test, confirming that the improved insulin signaling translated into better blood sugar control in a whole living animal.

This finding reframed how scientists think about fat tissue. Rather than being an inert storage depot, adipose tissue actively sends out palmitoleic acid as a chemical signal that tells muscles to take up more glucose and tells the liver to dial back fat production. The practical question, of course, is whether swallowing a capsule of palmitoleic acid reproduces this effect in humans. That research is still catching up to the animal data, and no large-scale human trial has definitively shown that omega-7 supplements lower blood sugar in people with diabetes. But the biological mechanism is well-established in animal models, which is more than many supplement ingredients can claim.

Lipid Profiles and Heart Health

Animal and preliminary human data suggest that palmitoleic acid can shift blood lipid numbers in a favorable direction. In mice and some small human studies, omega-7 supplementation has been associated with lower LDL cholesterol and reduced triglycerides. These are the lipid markers most closely tied to cardiovascular disease risk, so the interest from the cardiology world is understandable.

However, the picture gets more nuanced when you look at long-term observational data. A large study that followed older adults over more than two decades measured blood levels of various fatty acids serially and tracked who developed heart failure. Palmitoleic acid levels in the blood were not associated with incident heart failure, either positively or negatively.⁴ Interestingly, other fatty acids produced by the same metabolic pathway, like vaccenic acid and hexadecenoic acid, were positively linked to heart failure risk. This kind of result is a reminder that individual fatty acids in the same family can behave very differently in the body. Having higher circulating palmitoleic acid did not appear to be harmful in that cohort, but it did not appear protective either.

The disconnect between the short-term lipid improvements seen in supplementation trials and the neutral long-term observational data is not fully resolved. One explanation is that blood levels of palmitoleic acid reflect your body’s own production (driven partly by diet and partly by the liver’s fat-making machinery), while supplementation delivers it in a different metabolic context. Measuring a fatty acid in someone’s blood is not the same as measuring the effect of taking it as a pill.

The Inflammation Question

Omega-7 is frequently marketed as an anti-inflammatory supplement, and there is legitimate scientific basis for this claim in cell and animal studies. Palmitoleic acid has been shown to reduce the activity of pro-inflammatory signaling pathways in lab settings. But the most rigorous human trial to date on this topic found something different. A randomized, double-blind, placebo-controlled trial tested two different doses of palmitoleic acid oil against placebo in healthy adults and measured C-reactive protein (a standard marker of systemic inflammation) as the primary outcome. The result: palmitoleic acid at both doses had no effect on CRP or other measured inflammatory markers.⁵

This does not necessarily mean palmitoleic acid has no anti-inflammatory action in the body. The trial was conducted in healthy adults whose inflammation levels were already low, so there may not have been much room for improvement. It is possible that anti-inflammatory effects would appear in people with elevated baseline inflammation, such as those with obesity or metabolic syndrome. But the honest assessment right now is that the anti-inflammatory marketing for omega-7 supplements runs ahead of the human clinical evidence. If you are taking omega-7 specifically for inflammation, the data supporting that choice in humans is thin.

Skin Hydration and Wound Healing

The skin-related research on omega-7 splits into two areas: wound healing and barrier function in aging skin. In an animal study, topical application of palmitoleic acid directly accelerated wound closure in rats. Treated wounds were measurably smaller than untreated controls, and the researchers attributed the benefit to palmitoleic acid’s anti-inflammatory activity during the granulation and remodeling phases of healing.⁶

For everyday skin health rather than wound repair, a 12-week randomized, double-blind, placebo-controlled trial tested oral palmitoleic acid supplementation in people with aging skin. The supplement group showed significant improvements in skin hydration and a decrease in transepidermal water loss, which is a standard measure of how well the skin barrier is holding moisture in. The effects appeared around the six-week mark on some measurements and were consistent across multiple sites by week twelve.⁷ This is one of the more practically relevant human findings for omega-7. Skin dryness is a near-universal complaint as people age, and this trial, while single and modest in size, used a solid design and measured objective outcomes.

Dry Eyes and Mucous Membranes

Sea buckthorn oil, one of the richest natural sources of omega-7, has been studied for its effects on dry eye. In a randomized trial, participants who took sea buckthorn oil daily during the cold season (when dry eye symptoms typically worsen) experienced a significantly smaller increase in tear film osmolarity compared to those on placebo. Symptoms of redness and burning also trended lower in the sea buckthorn group, reaching statistical significance for some measures.⁸ The effect was a blunting of seasonal worsening rather than a dramatic cure, but for people who struggle with dry eyes every winter, even a partial benefit is worth knowing about.

A follow-up analysis looked at whether this benefit came from changes in the fatty acid composition of the tear film itself and found that it did not. The researchers suggested that carotenoids and tocopherols (vitamin E compounds) in the oil, or downstream products of its fatty acids, might be responsible for the positive effects on the meibomian glands, the tiny oil-producing glands in your eyelids.⁹ This is an important caveat: the dry eye benefit appears to come from sea buckthorn oil as a whole, not necessarily from palmitoleic acid in isolation. If you are considering omega-7 for dry eyes, a sea buckthorn oil product likely makes more sense than a purified palmitoleic acid supplement.

Sea buckthorn oil has also been tested for vaginal dryness in postmenopausal women. A randomized, double-blind trial found that women in the sea buckthorn group were roughly three times more likely to show improvement in the integrity of the vaginal lining compared to those on placebo.¹⁰ The overall vaginal health index also tended to improve, though the result narrowly missed conventional statistical significance. For women who cannot or prefer not to use estrogen-based therapies for vaginal dryness, sea buckthorn oil is at least an option with some controlled trial evidence behind it, which is more than most “natural” alternatives can say.

Liver Fat Accumulation

The lipokine research hinted at palmitoleic acid’s ability to suppress fat buildup in the liver, and subsequent animal studies have fleshed this out. In mice fed a high-fat diet, palmitoleic acid supplementation slowed body weight gain and prevented the increase of lipids in the liver.¹¹ More recently, researchers have begun to unravel one of the mechanisms involved: palmitoleic acid appears to inhibit a form of cell death called ferroptosis (iron-dependent oxidative damage) in liver cells. In mice with diet-induced fatty liver disease, palmitoleic acid reduced liver injury, improved insulin resistance, and shifted the balance of gene expression away from fat synthesis and toward fat breakdown.¹²

Non-alcoholic fatty liver disease affects a very large share of adults in developed countries, and there is no approved drug specifically for it, so any compound that shows consistent liver-protective effects in animal models gets attention. The usual caveat applies: these are mouse studies, and many promising mouse findings fail to translate to people. But the consistency across multiple research groups and the plausible mechanism make this an area worth watching.

Appetite and Satiety Signals

An intriguing line of research suggests palmitoleic acid can suppress appetite. When rats were given omega-7 by mouth, their food intake dropped significantly compared to animals given other fatty acids like palmitic acid or oleic acid (the main fat in olive oil). The effect was dose-dependent, meaning more palmitoleic acid produced more appetite suppression, and it did not appear to be caused by nausea. The mechanism traced to the gut: palmitoleic acid accumulated in the small intestine and triggered the release of cholecystokinin (CCK), a hormone that signals fullness to the brain. When researchers blocked CCK receptors, the appetite-suppressing effect was largely eliminated, confirming that the satiety signal ran through this specific hormonal pathway.¹³

Whether this translates into meaningful weight management in humans is unknown. Rat appetite studies often fail to predict human eating behavior, for obvious reasons (we eat for pleasure, social context, and habit in ways that rodents do not). But the CCK mechanism is well-understood in human physiology, and the finding at least provides a plausible reason why some people report feeling fuller when taking omega-7 supplements.

Cis Versus Trans Palmitoleic Acid

Not all omega-7 is created equal, and this is a point most supplement marketing glosses over. Palmitoleic acid comes in two geometric forms: cis-palmitoleic acid, which your body makes and which is found in plant sources, and trans-palmitoleic acid, which occurs naturally in dairy fat and ruminant meat. Despite being geometric mirror images of each other, these two forms behave differently inside cells. Research comparing the two isomers in pancreatic beta cells found that both boosted insulin secretion in response to glucose to a similar degree, but they did so through different signaling pathways and activated different cellular receptors.¹⁴

Trans-palmitoleic acid has attracted separate interest because some large epidemiological studies have linked higher blood levels of it (a marker of dairy fat consumption) with lower risk of type 2 diabetes. This stands in stark contrast to the general rule that trans fats are bad for you, and it highlights how blanket statements about fat categories can mislead. The trans fats in industrial partially hydrogenated oils are genuinely harmful, but naturally occurring trans-palmitoleic acid from dairy appears to be a different story. The debate about whether cis and trans palmitoleic acid have positive, negative, or neutral relationships with metabolic risk is still very much active in the research community.

Safety and Practical Considerations

Sea buckthorn oil, the most common whole-food source of supplemental omega-7, has been formally tested for toxicity in rodents. In acute toxicity studies, no mortality or signs of harm were observed even at very high doses. In a 90-day subchronic study, rats given daily sea buckthorn oil showed no treatment-related changes in body weight, organ weight, blood chemistry, or tissue examinations at any dose tested.¹⁵ While rodent safety data does not guarantee human safety, these results, combined with the long traditional use of sea buckthorn in several cultures, suggest that the oil has a wide safety margin.

One practical issue with sea buckthorn-based omega-7 supplements is that crude sea buckthorn oil also contains palmitic acid, a saturated fat. Some manufacturers offer “purified” products that concentrate the palmitoleic acid and reduce the palmitic acid content. If you are specifically interested in the metabolic effects attributed to palmitoleic acid and want to minimize your saturated fat intake, a purified product may be more appropriate. On the other hand, if your interest is in dry eyes or mucosal health, the full sea buckthorn oil with its carotenoids and vitamin E may be the better choice, since those companion nutrients appear to contribute to the benefits seen in trials.

When Your Own Body Ramps Up Production

There is a paradox in the omega-7 story that rarely makes it into popular health articles. Your liver can manufacture palmitoleic acid through a process called de novo lipogenesis, the same metabolic pathway that converts excess carbohydrates into fat. When people overeat, especially refined carbohydrates, the liver upregulates this pathway, and blood levels of palmitoleic acid can rise as a result. In observational studies, higher circulating palmitoleic acid sometimes correlates with metabolic syndrome, obesity, and insulin resistance, which seems to contradict the supplementation research showing benefits.

The resolution is that context matters enormously. Elevated palmitoleic acid in the blood of someone eating a caloric surplus is a marker of overactive liver fat production, not a cause of the metabolic problems. It is like seeing more firefighters at a bigger fire: the firefighters are not causing the blaze. Meanwhile, delivering palmitoleic acid directly via a supplement or food bypasses the liver’s fat-production machinery and can engage the lipokine signaling pathways that improve insulin sensitivity and reduce hepatic fat storage. Researchers have increasingly stressed the importance of distinguishing endogenous production (which tracks with metabolic dysfunction) from exogenous intake (which appears to have separate, potentially beneficial effects). An interesting finding from animal research is that caffeine can induce the expression of the SCD1 enzyme that converts palmitic acid into palmitoleic acid in fat tissue, at least in mice on a high-fat diet.¹⁶ Whether your morning coffee meaningfully shifts your omega-7 balance remains speculative, but it illustrates how many variables feed into your body’s palmitoleic acid levels beyond what you take as a supplement.

Muscle Cells and High Blood Sugar

A less-discussed area of omega-7 research involves its effects on muscle cell development under high-glucose conditions. In lab studies simulating a hyperglycemic environment, palmitoleic acid suppressed the expression of genes that drive muscle cell differentiation and instead promoted signals associated with cell proliferation. The trans and cis forms again diverged in their cellular behavior: trans-palmitoleic acid activated a growth-signaling pathway (MAPK/ERK) and reduced oxidative stress in the cells, while cis-palmitoleic acid inactivated that same pathway and increased oxidative stress.¹⁷ These findings are preliminary and limited to cell culture, but they suggest that omega-7’s relationship with muscle tissue is not straightforwardly positive, especially in people with poorly controlled blood sugar. It is another reminder that the effects of any fatty acid depend heavily on the metabolic environment it enters.